Beate Mayrbäurl

Most-cited papers

1. Quality of life across chemotherapy lines in patients with advanced colorectal cancer: a prospective single-center observational study

   Beate Mayrbäurl, J. Giesinger, S. Burgstaller, G. Piringer +2 more

   2016Supportive Care in Cancer41 citations

   Semantic Scholar

   Save

2. Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial.

   F. Keil, Maximilian Hartl, G. Altorjai, A. Berghold +10 more

   2021European Journal of Cancer19 citations

   Semantic Scholar

   Save

3. Oxaliplatin, irinotecan, and cetuximab in advanced gastric cancer. First efficacy results of a multicenter phase II trial (AGMT Gastric-2) of the Arbeitsgemeinschaft Medikamentoese Tumortherapie (AGMT).

   E. Woell, R. Greil, W. Eisterer, M. Fridrik +5 more

   2016Journal of Clinical Oncology18 citations

   Semantic Scholar

   Save

4. Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer. A multicenter phase II trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT).

   E. Wöll, R. Greil, W. Eisterer, Oliver E. Bechter +8 more

   2011Anticancer Research18 citations

   Semantic Scholar

   Save

5. Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer: First results of a multicenter phase II trial (AGMT Gastric- 2

   E. Woell, R. Greil, W. Eisterer, M. Fridrik +5 more

   200813 citations

   Semantic Scholar

   Save

6. Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria

   M. Balić, W. Hilbe, Sylvia Gusel, M. Fiegl +16 more

   2019memo - Magazine of European Medical Oncology12 citations Open access

   Semantic Scholar

   Save

7. Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe.

   G. Resch, R. Schaberl-Moser, P. Kier, G. Kopetzky +6 more

   2011Annals of Oncology11 citations Open access

   Semantic Scholar

   Save

8. Chemotherapy line-associated differences in quality of life in patients with advanced cancer

   Beate Mayrbäurl, L. Wintner, J. Giesinger, T. Himmelfreundpointner +3 more

   2012Supportive Care in Cancer7 citations

   Semantic Scholar

   Save

9. Experience with lenalidomide in an Austrian non-study population with advanced myelofibrosis

   S. Burgstaller, M. Fridrik, Sabine Hojas, T. Kühr +8 more

   2013Wiener Klinische Wochenschrift5 citations

   Semantic Scholar

   Save

10. Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone

    T. Magnes, S. Wagner, T. Melchardt, L. Weiss +10 more

    2021Wiener Klinische Wochenschrift4 citations Open access

    Semantic Scholar

    Save

11. Induction chemotherapy with docetaxel, cisplatin and cetuximab versus docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced or inoperable squamous cell carcinoma of the head and neck: Promising results of a randomized phase II AGMT-trial.

    F. Keil, Maximilian Hartl, G. Altorjai, M. Pecherstorfer +8 more

    2019Journal of Clinical Oncology0 citations

    Semantic Scholar

    Save

12. [Cancer in the elderly].

    Beate Mayrbäurl, J. Thaler

    2004Acta Medica Austriaca0 citations

    Semantic Scholar

    Save